Medicinal mushroom β-glucans

Category: signaling

Overview

β(1→3)/β(1→6)-glucans from fungal cell walls are pathogen-associated molecular patterns recognized by Dectin-1 (CLEC7A) on macrophages + dendritic cells → Syk → CARD9 → NF-κB → cytokine release; also complement-mediated CR3-binding on neutrophils. Mushroom polysaccharide extracts: PSK + PSP (Trametes versicolor / turkey tail) — adjuvant in stomach + colorectal cancer in Japanese pharmacy schedule; lentinan (Shiitake — Japanese IV cancer adjuvant); maitake D-fraction; cordyceps polysaccharides + cordycepin (adenosine analog with antiviral / immunomodulatory activity); reishi triterpenes + polysaccharides; chaga (Inonotus obliquus) — birch tree pathogen, betulinic acid + melanin; lions mane (Hericium erinaceus) — hericenones + erinacines stimulate NGF synthesis (nootropic claim).

Organ Systems

Pathway Steps

  1. fungal-beta-glucan → innate-immune-activation — via Dectin-1 + complement CR3 + TLR2 → Syk → CARD9 → NF-κB → cytokine secretion + adaptive immune priming. β-glucans from medicinal mushrooms (and yeast/fungi) are recognized by the innate immune receptor Dectin-1 (and CR3) on macrophages and dendritic cells, activating them and shaping downstream immunity. This pattern-recognition mechanism is the basis for β-glucans’ proposed immunomodulatory and adjuvant effects.

Known Modulators

References